To see the other types of publications on this topic, follow the link: Cholecystostomy.

Journal articles on the topic 'Cholecystostomy'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Cholecystostomy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

de Mestral, Charles, David Gomez, Barbara Haas, Brandon Zagorski, Ori D. Rotstein, and Avery B. Nathens. "Cholecystostomy." Journal of Trauma and Acute Care Surgery 74, no. 1 (January 2013): 175–80. http://dx.doi.org/10.1097/ta.0b013e31827890e1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ramsay, Duncan W., Caroline J. Newland, Gillian A. Townson, and Antony C. Wicks. "Cholecystostomy." European Journal of Gastroenterology & Hepatology 11, no. 12 (December 1999): 1429–30. http://dx.doi.org/10.1097/00042737-199912000-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Snyder, Austin, Silvia Salamone, Nicholas J. Reid, Tristan Yeung, John Di Capua, Avik Som, Dania Daye, and Raul Uppot. "Retrospective evaluation of image-guided cholecystostomy tube utilization and outcomes during the first wave of the COVID-19 pandemic." American Journal of Interventional Radiology 5 (August 11, 2021): 13. http://dx.doi.org/10.25259/ajir_11_2021.

Full text
Abstract:
Objectives: During the COVID-19 pandemic, there was a perceived increase in the number of cholecystostomy tube placements. We have retrospectively analyzed the incidence and outcomes of cholecystostomy tube placement during the COVID-19 pandemic surge. Material and Methods: Cholecystostomy tube placement and overall interventional radiology (IR) case volume were analyzed at our tertiary care center during the pandemic (March 15, 2020–July 30, 2020) and compared to the same time period in 2019. In addition, an age- and gender-matched control study of outcomes for 40 patients (25 from our home institution and 15 from our affiliated hospitals) grouped by COVID-19 status who received percutaneous cholecystostomy tubes between March 15, 2020, and July 30, 2020, was performed. Results: We observed a significant increase in relative cholecystostomy tube volume during the pandemic, despite a decrease in total IR case volume. There was no significant difference in pre- or post-procedural laboratory data, vital signs, imaging, or mortality between COVID-positive and COVID-negative patients who received cholecystostomy tubes. Conclusion: Percutaneous cholecystostomy tube placement is likely a safe treatment for acalculous cholecystitis in patients with COVID-19 with equivalent outcomes to patients without COVID-19.
APA, Harvard, Vancouver, ISO, and other styles
4

Yoon, Y., C. K. Lee, D. H. Lee, Y. T. Ko, and J. H. Lim. "Percutaneous cholecystostomy." Journal of the Korean Radiological Society 26, no. 1 (1990): 121. http://dx.doi.org/10.3348/jkrs.1990.26.1.121.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gervais, Debra, and Peter Mueller. "Percutaneous Cholecystostomy." Seminars in Interventional Radiology 13, no. 01 (March 1996): 35–43. http://dx.doi.org/10.1055/s-2008-1057890.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Akhan, Okan, Devrim Akıncı, and Mustafa N. Özmen. "Percutaneous cholecystostomy." European Journal of Radiology 43, no. 3 (September 2002): 229–36. http://dx.doi.org/10.1016/s0720-048x(02)00158-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hawkins, Irvin. "Percutaneous Cholecystostomy." Seminars in Interventional Radiology 2, no. 01 (March 1985): 97–103. http://dx.doi.org/10.1055/s-2008-1076073.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jiang, Hua, Guo Guo, Zhimin Yao, and Yuehua Wang. "APACHE IV system helps to determine role of cholecystostomy in elderly patients with acute cholecystitis." Journal of International Medical Research 49, no. 11 (November 2021): 030006052110592. http://dx.doi.org/10.1177/03000605211059288.

Full text
Abstract:
Objective Cholecystostomy is a palliative treatment for patients unfit to undergo immediate cholecystectomy. Nevertheless, the role of cholecystostomy in the clinical management of such patients remains unclear. The Acute Physiology and Chronic Health Evaluation IV (APACHE IV) scoring system is useful for estimating the hospital mortality of high-risk patients. We evaluated the therapeutic effect of cholecystostomy by the APACHE IV scoring system in patients aged >65 years with acute cholecystitis. Methods In total, 597 patients aged >65 years with acute cholecystitis were retrospectively analyzed using APACHE IV scores. Results The fitness of the APACHE IV score prediction was good, with an area under the receiver operating characteristic curve of 0.894. The chi square independence test indicated that compared with conservative treatment, cholecystostomy may have different effects on mortality for patients whose estimated mortality rate was >10%. Comparison of the estimated mortality of patients before and after cholecystostomy indicated that the estimated mortality was significantly lower after than before puncture, both in the whole patient group and in the group with an estimated mortality of >10%. Conclusion The APACHE IV scoring system showed that cholecystostomy is a safe and effective treatment for elderly high-risk patients with acute cholecystitis.
APA, Harvard, Vancouver, ISO, and other styles
9

Morse, Bryan C., J. Brandon Smith, Richard B. Lawdahl, and Richard H. Roettger. "Management of Acute Cholecystitis in Critically Ill Patients: Contemporary Role for Cholecystostomy and Subsequent Cholecystectomy." American Surgeon 76, no. 7 (July 2010): 708–12. http://dx.doi.org/10.1177/000313481007600724.

Full text
Abstract:
The diagnosis of acute cholecystitis in critically ill patients carries a high mortality rate. Although decompression and drainage of the gallbladder through a cholecystostomy tube may be used as a temporary treatment of acute cholecystitis in this population, there is still some debate about the management of the tube and the subsequent need for a cholecystectomy. This series evaluates the clinical course and outcomes of critically ill patients who underwent the insertion of cholecystostomy tubes for the initial treatment of acute cholecystitis. This is a retrospective review of critically ill patients admitted to the hospital intensive care unit who were diagnosed with acute cholecystitis and underwent a cholecystostomy tube as a temporary treatment for the disease. Patients were identified through the Greenville Hospital System electronic medical records coding database. Medical records were reviewed for demographic data, diagnoses, imaging, complications, and outcomes. From January 2002 through June 2008, 50 patients were identified for the study. The mean age was 72 ± 11 years, and the majority (66%) were men. The following comorbidities were found: severe cardiovascular disease (40 patients), respiratory failure (30 patients), and multisystem organ dysfunction (30 patients). The mean intensive care unit length of stay (LOS) was 16 ± 9 days, and the mean hospital LOS was 28 ± 27 days. At 30 days, the morbidity associated with the cholecystostomy tube itself was 4 per cent, but overall in-hospital morbidity and mortality rates were 62 and 50 per cent, respectively. Of the 25 patients who survived longer than 30 days, 12 retained their cholecystostomy tubes until they underwent cholecystectomy (four open, seven laparoscopic). All of the remaining 13 patients had their cholecystostomy tubes removed, and eight developed recurrent cholecystitis. Of these patients with recurrent of cholecystitis, five had cholecystectomy or repeat cholecystostomy, but the remaining three patients died. Although this is a small patient population, these data suggest that, in critically ill patients, cholecystostomy tubes should remain in place until the patient is deemed medically suitable to undergo cholecystectomy. Removal of the cholecystostomy tube without subsequent cholecystectomy is associated with a high incidence of recurrent cholecystitis and devastating consequences.
APA, Harvard, Vancouver, ISO, and other styles
10

Haicken, Barry N. "Laparoscopic tube cholecystostomy." Surgical Endoscopy 6, no. 6 (November 1992): 285–88. http://dx.doi.org/10.1007/bf02498861.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Lameris, J., J. Jeekel, I. Havelaar, and A. v. Seyen. "Percutaneous transhepatic cholecystostomy." RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 142, no. 01 (January 1985): 80–82. http://dx.doi.org/10.1055/s-2008-1052604.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Lois, Alex W., Erin Fennern, Sara B. Cook, David R. Flum, and Giana H. Davidson. "Cholecystectomy After Cholecystostomy?" Journal of the American College of Surgeons 231, no. 4 (October 2020): e122. http://dx.doi.org/10.1016/j.jamcollsurg.2020.08.318.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

McGahan, J. P., and K. K. Lindfors. "Percutaneous cholecystostomy: an alternative to surgical cholecystostomy for acute cholecystitis?" Radiology 173, no. 2 (November 1989): 481–85. http://dx.doi.org/10.1148/radiology.173.2.2678261.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Sinitsyn, Aleksey G., Andrei I. Perepelkin, and Gleb A. Kopan. "Features of diagnosis and treatment of a child with choledochal cyst IС type." Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care 14, no. 2 (July 16, 2024): 257–66. http://dx.doi.org/10.17816/psaic1796.

Full text
Abstract:
Choledochal cysts are congenital cystic dilatations of the extrahepatic and/or intrahepatic bile ducts. Diagnosis and choice of treatment tactics for this pathology often cause difficulties. A case report of a choledochal cyst in a 2-year-old patient with symptoms of recurrent jaundice, cholangitis, and pancreatitis, which required laparoscopic cholecystostomy and cholangiography during preparation for radical surgery, was retrospectively analyzed. The child was re-admitted to the pediatric surgical department with complaints of hyperthermia up to 39°C, resumption of periodic abdominal pain, nausea, and increased icterus of the sclera and skin. Laboratory and ultrasound examination indicated biliary and pancreatic hypertension. Choledochal cyst, cholestasis syndrome, acute cholecystopancreatitis was diagnosed. Owing to the existing clinical symptoms and laboratory and ultrasound data, laparoscopic cholecystostomy was urgently performed. Against the background of conservative therapy, within 2 days after laparoscopic cholecystostomy, clinically, laboratory and according to control ultrasound examination, biliary and pancreatic hypertension were stopped. The child underwent cholangiography through a cholecystostomy without additional anesthesia, which revealed a fusiform dilatation of the common hepatic and bile ducts. After 2 weeks of drug treatment against the background of laparoscopic cholecystostomy, the child underwent excision of the common bile duct cyst, and cholecystectomy with hepatic enteroanastomosis on a Roux-en-Y loop. The postoperative period was smooth. No other complaints or complications were noted within 24 months. In the reported case, recurrent obstructive jaundice was caused by a choledochal cyst. Laparoscopic cholecystostomy enabled the quick and successful relief of biliary hypertension, preparation of the patient for radical surgical treatment, and safe informative cholangiography through cholecystostomy. Hepatic enteroanastomosis with a disconnected loop according to Roux-en-Y was an effective surgical treatment method for choledochal cyst.
APA, Harvard, Vancouver, ISO, and other styles
15

Aroori, S., C. Mangan, L. Reza, and N. Gafoor. "Percutaneous Cholecystostomy for Severe Acute Cholecystitis: A Useful Procedure in High-Risk Patients for Surgery." Scandinavian Journal of Surgery 108, no. 2 (September 18, 2018): 124–29. http://dx.doi.org/10.1177/1457496918798209.

Full text
Abstract:
Background: Acute cholecystitis has the potential to cause sepsis and death, particularly in patients with poor physiological reserve. The gold standard treatment of acute cholecystitis (cholecystectomy) is often not safe in high-risk patients and recourse is made to percutaneous cholecystostomy as either definite treatment or temporizing measure. The aim of this study is to evaluate early and late outcomes following percutaneous cholecystostomy in patients with acute cholecystitis treated at our institution. Methods: All patients who underwent percutaneous cholecystostomy for acute cholecystitis (excluding patients with malignancy) between January 2005 and September 2014 were included in the study. Results: A total of 53 patients (22 female, median age, 74 years; range, 27–95 years) underwent percutaneous cholecystostomy during the study period. In total, 12 patients (22.6%) had acalculous cholecystitis. The main indications for percutaneous cholecystostomy were significant co-morbidities (n = 28, 52.8%) and patients too unstable for surgery (n = 21, 39.6%). The median time to percutaneous cholecystostomy from diagnosis of acute cholecystitis was 3.6 days (range, 0–45 days). The median length of hospital stay was 27 (range, 4–87) days. The overall 90-day mortality was 9.3% with two further deaths at 12-month follow up. The mortality was significantly higher in patients with American Society of Anesthesiology grade 4–5 (18% vs 0% in American Society of Anesthesiology grade 2–3, p = 0.026) and in patients with acalculous cholecystitis (25% vs 4.5%, p = 0.035). The overall readmission rate was 18%. A total of 24 (45.2%) patients had surgery: laparoscopic cholecystectomy, n = 11; laparoscopic converted to open, n = 5; open total cholecystectomy, n = 5; open cholecystectomy, n = 1; laparotomy and washout, n = 1; laparotomy partial cholecystectomy and closure of perforated small intestine and gastrostomy, n = 1. Conclusion: Percutaneous cholecystostomy is a useful temporary or permanent procedure in patients with acute cholecystitis of both calculous and acalculous origin, who are unfit for surgery.
APA, Harvard, Vancouver, ISO, and other styles
16

Boules, M., I. N. Haskins, M. Farias-Kovac, A. D. Guerron, D. Schechtman, M. Samotowka, C. P. O’Rourke, G. McLennan, R. M. Walsh, and G. Morris-Stiff. "What is the fate of the cholecystostomy tube following percutaneous cholecystostomy?" Surgical Endoscopy 31, no. 4 (August 12, 2016): 1707–12. http://dx.doi.org/10.1007/s00464-016-5161-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Mcgahan, John P. "Percutaneous Cholecystectomy in the Intensive Care Patient." Journal of Intensive Care Medicine 13, no. 2 (March 1998): 78–84. http://dx.doi.org/10.1177/088506669801300205.

Full text
Abstract:
The diagnosis of acute cholecystitis in the intensive care patient is often problematic. While most patients with acute cholecystitis present with fever, increased white count, or symptomatology pertaining to the gallbladder, occasionally these patients may be comatose and often present a diagnostic dilemma. Surgical cholecystectomy is the treatment of choice for acute cholecystitis, but this therapy carries with it a high mortality rate in the desperately ill patient. Thus surgical cholecystostomy has been advocated as a temporizing procedure to be performed until these patients stabilize. More recently percutaneous cholecystostomy, performed at the patient's bedside under ultrasound guidance, has been successfully performed using small-size catheters. This is a low-risk temporizing procedure when performed by well-trained personnel. In fact, percutaneous cholecystostomy has been shown to be a definitive treatment in patients with acute acalculous cholecystitis. Patients with calculous cholecystitis may require more definitive therapy, such as cholecystectomy. Presented is a review of the development and the current applications of percutaneous cholecystostomy in intensive care patients with suspected acute cholecystitis.
APA, Harvard, Vancouver, ISO, and other styles
18

Antalek, Matthew, Ahsun Riaz, and Albert A. Nemcek. "Gallbladder: Role of Interventional Radiology." Seminars in Interventional Radiology 38, no. 03 (August 2021): 330–39. http://dx.doi.org/10.1055/s-0041-1731371.

Full text
Abstract:
AbstractPercutaneous cholecystostomy is an established procedure for the management of patients with acute cholecystitis and with significant medical comorbidities that would make laparoscopic cholecystectomy excessively risky. In this review, we will explore the role of percutaneous cholecystostomy in the management of acute cholecystitis as well as other applications in the management of biliary pathology. The indications, grading, technical considerations, and postprocedure management in the setting of acute cholecystitis are discussed. In addition, we will discuss the potential role of percutaneous cholecystostomy in the management of gallstones and biliary strictures, in establishing internal biliary drainage, and in a joint setting with other clinicians such as gastroenterologists in the management of complex biliary pathology.
APA, Harvard, Vancouver, ISO, and other styles
19

Cheeyandira, Abhiman. "Laparoscopic cholecystostomy tube placement." MOJ Clinical & Medical Case Reports 10, no. 3 (2020): 70–72. http://dx.doi.org/10.15406/mojcr.2020.10.00346.

Full text
Abstract:
Laparoscopic cholecystectomy is one of the most common procedures performed in the world today Acute calculus cholecystitis is the most frequent complication of cholelithiasis. Laparoscopic cholecystectomy is the best treatment for acute calculus cholecystitis when performed within 72 hours. Acute cholecystitis tends to be one of the highest risks for conversion to open surgery-due to unclear anatomy, excessive bleeding or technical complications. Here we present 2 cases with severe acute cholecystitis that required placement of laparoscopic cholecystostomy (LC) tube. Patient subsequently underwent interval cholecystectomy, when the inflammation had subsided. LC tube placement can be a safe alternative in such situations to avoid complications and conversion to open procedure.
APA, Harvard, Vancouver, ISO, and other styles
20

Anand, Rahul J., Laurie Punch, Amy C. Sisley, Steven b. Johnson, and Matthew Lissauer. "Outcomes of Percutaneous Cholecystostomy." Panamerican Journal of Trauma, Critical Care & Emergency Surgery 1, no. 1 (2012): 20–23. http://dx.doi.org/10.5005/jp-journals-10030-1005.

Full text
Abstract:
ABSTRACT Objective Emergency cholecystectomy in patients with severe comorbidities carries up to 30% mortality. Percutaneous cholecystostomy (PC) is accepted as acute management in these patients. This study evaluated outcomes of PC and the need for subsequent cholecystectomy. Methods Retrospective chart review evaluated all patients undergoing PC between June 1, 2005 and January 1, 2010. Results Fifty four patients underwent PC. Indications included acute calculous cholecystitis (44%), acalculous cholecystitis (33%) and other (22%). Twelve patients had PC related complications. Seventeen patients underwent CCY 144 ± 133 days after PC placement. 71% of those procedures were converted to open operation. 15% of patients had PC tube removed successfully without cholecystectomy, 62 ± 53 days after PC. Fifteen patients died in hospital after PC, four likely related to biliary pathology. Patients who underwent subsequent cholecystectomy were more likely to have had a diagnosis of acute cholecystitis (71% vs 33%, p < 0.05). Patients with a diagnosis of acalculous cholecystitis trended toward a higher likelihood of death compared to acute cholecystitis (8 of 18, 44% vs 4 of 24, 17%, p = 0.08). Conclusion PC can be definitive treatment in a minority of patients with acalculous cholecystitis and severe comorbidities. Interval cholecystectomy carries a high complication rate. How to cite this article Ferrada PA, Anand RJ, Punch L, Sisley AC, Johnson SB, Lissauer M . Outcomes of Percutaneous Cholecystostomy. Panam J Trauma Critical Care Emerg Surg 2012;1(1):20-23.
APA, Harvard, Vancouver, ISO, and other styles
21

England, R. E., V. G. McDermott, T. P. Smith, P. V. Suhocki, C. S. Payne, and G. E. Newman. "Percutaneous cholecystostomy: who responds?" American Journal of Roentgenology 168, no. 5 (May 1997): 1247–51. http://dx.doi.org/10.2214/ajr.168.5.9129421.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

England, R. E., V. G. McDermot, G. E. Newman, P. V. Suhocki, C. S. Payne, and T. P. Smith. "Percutaneous cholecystostomy: Who responds?" Clinical Radiology 49, no. 10 (October 1994): 763. http://dx.doi.org/10.1016/s0009-9260(05)82820-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Mendez, Alejandro, Jorge Mancera-Maldonado, and Flavio Castañeda. "Complications of Percutaneous Cholecystostomy." Seminars in Interventional Radiology 11, no. 03 (September 1994): 283–86. http://dx.doi.org/10.1055/s-2008-1074766.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Lindemann, Steven, Glenn Tung, Stuart Silverman, and Peter Mueller. "Percutaneous Cholecystostomy - A Review." Seminars in Interventional Radiology 5, no. 03 (September 1988): 179–85. http://dx.doi.org/10.1055/s-2008-1075952.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Warren, L. P., S. Kadir, and N. R. Dunnick. "Percutaneous cholecystostomy: anatomic considerations." Radiology 168, no. 3 (September 1988): 615–16. http://dx.doi.org/10.1148/radiology.168.3.3406392.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Hawkyard, S. J., S. J. Walker, and S. Holt. "Cholecystostomy: a safe alternative?" International Journal of Clinical Practice 44, no. 12 (December 1990): 593–95. http://dx.doi.org/10.1111/j.1742-1241.1990.tb10110.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Martiny, Pia, and Galina Hayes. "Placement of a temporary cholecystostomy tube to relieve pancreatic EHBDO in a dog." Veterinary Record Case Reports 7, no. 3 (July 2019): e000878. http://dx.doi.org/10.1136/vetreccr-2019-000878.

Full text
Abstract:
A 12-year-old male neutered labrador retriever was treated for extrahepatic bile duct obstruction (EHBDO) secondary to acute pancreatitis. Supportive care was provided for 14 days, but despite treatment the dog’s clinical condition worsened. A temporary cholecystostomy tube was placed via minilaparotomy to provide extracorporeal diversion of bile until patency of the common bile duct was spontaneously re-established. Within 24 hours of tube placement, marked improvement in total bilirubin was noted and the dog could be managed as an outpatient. Clinical signs resolved rapidly, and despite complications with the external tubing necessitating replacement after 48 hours the procedure and tube were well tolerated. Patency of the common bile duct was spontaneously re-established three weeks after tube placement, and the cholecystostomy tube was removed percutaneously. No recurrence of EHBDO was noted in the 13 months following removal of the cholecystostomy tube.
APA, Harvard, Vancouver, ISO, and other styles
28

Rajah, Kumar Hari. "Percutaneous cholecystostomy in acute cholecystitis – Narrative review article." Yemen Journal of Medicine 3, no. 1 (May 6, 2024): 21–24. http://dx.doi.org/10.32677/yjm.v3i1.4406.

Full text
Abstract:
Percutaneous cholecystostomy is often performed to treat high-risk patients with acute cholecystitis who are not suitable for cholecystectomy. It is performed by the interventional radiologist and can be performed through the transhepatic or transperitoneal route (direct gallbladder puncture, without passing through the liver). Percutaneous cholecystostomy is used as a bridging procedure to stabilize high-risk patients with acute cholecystitis. We prepared this narrative review article to describe the indications for performing this procedure and the consequences of its performance and to compare it with emergency cholecystectomy.
APA, Harvard, Vancouver, ISO, and other styles
29

Slama, Eliza M., Motahar Hosseini, Ryan M. Staszak, and Viney R. Setya. "Open Cholecystostomy Under Local Anesthesia for Acute Cholecystitis in the Elderly and High-Risk Surgical Patients." American Surgeon 88, no. 3 (November 4, 2021): 434–38. http://dx.doi.org/10.1177/00031348211050593.

Full text
Abstract:
Background The morbidity and mortality rates associated with cholecystectomy for acute cholecystitis are higher in the critically ill elderly population. As an alternative to cholecystectomy, we report the results of treatment of acute cholecystitis in the elderly after open cholecystolithotomy with cholecystostomy tube placement under local anesthesia. Methods A case series was performed on 5 patients from August 2007 to April 2010 who presented with acute cholecystitis and underwent an open cholecystolithotomy and tube placement. Thirty-day mortality, intra- and immediate-postoperative complications, clinical improvement after drainage, additional biliary procedures needed, and outcome after cholecystostomy tube removal were recorded. Results Open cholecystolithotomy and tube placement were performed successfully in all patients and permitted resolution of the acute attack in all after a mean period of 3.75 days. Thirty-day mortality was 0%. Patients did not experience any intraoperative complications. We observed 100% rate of successful short-term outcomes in our patients including resolution pain, and objectively, normalization of leukocytosis, and defervescence. None of the patients required emergency cholecystectomy. All patients had their cholecystostomy tubes removed at a mean postoperative day 27. There were no cases of biliary leakage or tube dislodgement. There were no recurrences of acute cholecystitis within the mean follow-up of 20.75 months. Discussion Emergency open cholecystolithotomy and cholecystostomy tube placement represent an effective, safe, and definitive alternative treatment strategy for acute gallstone cholecystitis in selected elderly patients with a mortality rate of 0% in the authors’ experience.
APA, Harvard, Vancouver, ISO, and other styles
30

Ginat, Daniel, and Wael E. A. Saad. "Cholecystostomy and Transcholecystic Biliary Access." Techniques in Vascular and Interventional Radiology 11, no. 1 (March 2008): 2–13. http://dx.doi.org/10.1053/j.tvir.2008.05.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Dimou, Francesca M., and Taylor S. Riall. "Proper Use of Cholecystostomy Tubes." Advances in Surgery 52, no. 1 (September 2018): 57–71. http://dx.doi.org/10.1016/j.yasu.2018.03.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Ahmad, N., A. Hussain, S. Zino, and A. Jabbar. "Percutaneous cholecystostomy – criteria and outcome." HPB 18 (April 2016): e513. http://dx.doi.org/10.1016/j.hpb.2016.03.364.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Flexer, SM, MB Peter, AC Durham-Hall, and JR Ausobsky. "Patient outcomes after treatment with percutaneous cholecystostomy for biliary sepsis." Annals of The Royal College of Surgeons of England 96, no. 3 (April 2014): 229–33. http://dx.doi.org/10.1308/003588414x13814021679799.

Full text
Abstract:
Introduction Acute cholecystitis is among the most common general surgical presentations. There is a cohort of patients who develop systemic sepsis and complications of acute cholecystitis. These patients are often elderly and co-morbid. Conservative management with percutaneous cholecystostomy has been shown to be a safe and effective management option in the acute setting. However, there is currently no consensus for the further management of these patients. In particular, there is a paucity of data on readmission rates and subsequent operative or non-operative management. Methods A retrospective study was carried out of patients treated with a percutaneous cholecystostomy for biliary sepsis over a three-year period in a UK teaching hospital. Outcome measures were subsequent operative or conservative management, conversion rates, operative complications and readmission rates. Results Twenty-five patients had a percutaneous cholecystostomy for the treatment of acute biliary sepsis. The median follow-up duration was 35 months. Thirteen patients (52%) had operative treatment. In the operative group, 6/13 had a laparoscopic cholecystectomy, 2/13 had a planned open cholecystectomy, 2/13 had abandoned procedures and 3/13 had a converted procedure. Complications in the operative group included: postoperative mortality (1/13), common bile duct injury requiring drainage and endoscopic stenting (1/13) and one patient required readmission with recurrent pain. In the non-operative group, 5/12 patients were readmitted with biliary sepsis, 5/12 had no readmissions, 1/12 died in the community and 1/12 was readmitted with biliary colic. Conclusions Percutaneous cholecystostomy is a recognised treatment modality for elderly, co-morbid patients with biliary sepsis. Nevertheless, the readmission rate in this group is relatively high at 5/12 (42%). Patients who undergo subsequent operative management have a conversion rate of 3/13 (23%) and a significant complication rate of 2/13 (15%). The further management of patients having undergone percutaneous cholecystostomy requires careful consideration on an individual case basis. The P-POSSUM (Portsmouth Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity) may aid decision making.
APA, Harvard, Vancouver, ISO, and other styles
34

Dabus, Guilherme de Castro, Sérgio San Juan Dertkigil, and Jamal Baracat. "Percutaneous cholecystostomy: a nonsurgical therapeutic option for acute cholecystitis in high-risk and critically ill patients." Sao Paulo Medical Journal 121, no. 6 (2003): 260–62. http://dx.doi.org/10.1590/s1516-31802003000600009.

Full text
Abstract:
Percutaneous cholecystostomy offers a potentially important type of therapy for critically ill patients with acute cholecystitis who present high risk when undergoing laparotomy or laparoscopy under general anesthesia. It offers a distinct advantage for these kinds of patients by avoiding the risks of the surgical intervention. Percutaneous cholecystostomy is a safe and effective minimally invasive procedure with a high success rate and low procedure-related complications. It should be considered not only in temporary management of calculous cholecystitis, but also in definitive treatment in cases of acalculous cholecystitis.
APA, Harvard, Vancouver, ISO, and other styles
35

Rajah, Kumar Hari. "Conservative Treatment of Acute Cholecystitis: An Updated Narrative Review." Asian Journal of Medicine and Health 22, no. 6 (April 16, 2024): 77–83. http://dx.doi.org/10.9734/ajmah/2024/v22i61022.

Full text
Abstract:
Conservative treatment of acute cholecystitis has been the initial treatment for acute cholecystitis, which involves the use of antibiotics to control the infection and prepare the patient for cholecystectomy. The Tokyo Guidelines have categorized patients who present with acute cholecystitis into three categories: Categories one, two and three. Although laparoscopic cholecystectomy is the gold standard of treatment, antibiotics and percutaneous cholecystostomy play a role in the management of patients with category two and three. This review aimes to examine the role of antibiotics and percutaneous cholecystostomy in the management of acute cholecystitis.
APA, Harvard, Vancouver, ISO, and other styles
36

Patel, Mrunal, Brent W. Miedema, Mark A. James, and John B. Marshall. "Percutaneous Cholecystostomy is an Effective Treatment for High-Risk Patients with Acute Cholecystitis." American Surgeon 66, no. 1 (January 2000): 33–37. http://dx.doi.org/10.1177/000313480006600107.

Full text
Abstract:
We sought to determine the safety, efficacy, and outcome of percutaneous cholecystostomy (PC) in all patients undergoing the procedure at our institutions. We reviewed 53 consecutive cases of acute cholecystitis seen at our hospitals over 5.5 years in which PC was performed at the initial treatment. Follow-up was obtained by chart review and telephone questionnaire. Acute cholecystitis was the primary admitting diagnosis in 18 cases. In the remaining 35, cholecystitis developed during hospitalization. All patients were considered high surgical risks on the basis of the presence of comorbid conditions. The gallbladder was successfully catheterized under radiologic guidance in all patients and with no immediate procedure-related morbidity. Acute cholecystitis resolved in 44 of 53 patients (83%), whereas nine patients (17%) did not improve clinically after PC and died during the same hospitalization. A total of 33 (62%) eventually survived hospitalization. Elective cholecystectomy was done in 25 patients with no mortality. After cholecystectomy, three of these patients subsequently died of other causes, whereas 22 are alive. Eight patients did not undergo cholecystectomy because of underlying medical conditions or because they had acalculous cholecystitis. These patients remained free of biliary problems after removal of their cholecystostomy tube, but two have subsequently died of nonbiliary conditions. Percutaneous cholecystostomy is a safe, effective treatment for high-risk patients with acute cholecystitis. Cholecystostomy can be followed by elective cholecystectomy at a later time if the patient's condition permits or by expectant conservative management in patients who have had acalculous cholecystitis or have a very high mortality risk with surgery.
APA, Harvard, Vancouver, ISO, and other styles
37

Han, S. P. "Laparoscopic cholecystostomy as an alternative to open cholecystectomy and percutaneous cholecystostomy in a rural setting." HPB 18 (April 2016): e490. http://dx.doi.org/10.1016/j.hpb.2016.03.296.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Oh, Dongwook, Tae Jun Song, Dong Hui Cho, Do Hyun Park, Dong-Wan Seo, Sung Koo Lee, Myung-Hwan Kim, and Sang Soo Lee. "EUS-guided cholecystostomy versus endoscopic transpapillary cholecystostomy for acute cholecystitis in high-risk surgical patients." Gastrointestinal Endoscopy 89, no. 2 (February 2019): 289–98. http://dx.doi.org/10.1016/j.gie.2018.08.052.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Soleimani, Mehrdad, Arianeb Mehrabi, Zhoobin A. Mood, Hamidreza Fonouni, Arash Kashfi, Markus W. BÜChler, and Jan Schmidt. "Partial Cholecystectomy as a Safe and Viable Option in the Emergency Treatment of Complex Acute Cholecystitis: A Case Series and Review of the Literature." American Surgeon 73, no. 5 (May 2007): 498–507. http://dx.doi.org/10.1177/000313480707300516.

Full text
Abstract:
Partial cholecystectomy (PC) is an alternative choice to standard cholecystectomy in situations with increased risk of Calot's components injury. We reported our experience with the patients treated with PC and reviewed the literature. Fifty-four patients with complex acute cholecystitis underwent PC, including conventional partial cholecystectomy (CPC; n = 48) and laparoscopic partial cholecystectomy (LPC; n = 6). The clinical diagnosis was verified by ultrasonography. In addition, we reviewed 1190 published cases (1972–2005) who underwent a “nonconventional” surgery for severe cholecystitis, including cholecystostomy, CPC, or LPC. Review of the literature, including our cases, showed a male:female ratio of 1.3:1. The major operative indication was severe acute cholecystitis. Procedures included cholecystostomy (65.8%) and PC (34.2%). In the follow-up (n = 1190), biliary leak (4.8%), retained stones (4.6%), recurrent symptoms (2.3%), wound infections (1.9%), persistent biliary fistula (0.9%), and prolonged biliary drainage (0.2%) were found, with an overall mortality rate of 9.4 per cent. In 133 patients, because of postoperative complications ( e.g., recurrent symptoms, remaining common bile duct stones, or persistence of bile fistula), reoperation was necessary, including 121 cases (90.1%) of cholecystectomy, whereas the other 11 patients underwent other procedures such as common bile duct exploration or closure of the fistula. The surgical trend for complex acute cholecystitis treatment has been changed from only cholecystostomy to a spectrum of cholecystostomy, CPC, and LPC with the progressive increase of PC. The proportion of the LPC compared with CPC has also increased during recent years. It seems that PC is a safe procedure for treating complicated acute cholecystitis. Whether the indication and need for alternative techniques to standard cholecystectomy is changing should be evaluated in future studies.
APA, Harvard, Vancouver, ISO, and other styles
40

Elsharif, M., A. Forouzanfar, K. Oaikhinan, and Niraj Khetan. "Percutaneous cholecystostomy… why, when, what next? A systematic review of past decade." Annals of The Royal College of Surgeons of England 100, no. 8 (November 2018): 618–31. http://dx.doi.org/10.1308/rcsann.2018.0150.

Full text
Abstract:
IntroductionPercutaneous cholecystostomy tube drainage has played a vital role in management of cholecystitis in patients where surgery is not appropriate. However, management differs from unit to unit and even between different consultants in the same unit. We conducted this systematic review to understand which of these resulted in the best patient outcomes.MethodsWe conducted a systematic review using the PubMed database for publication between January 2006 to December 2016. Keyword variants of ‘cholecystostomy’ and ‘cholecystitis’ were combined to identify potential relevant papers for inclusion.FindingsWe identified 46 studies comprising a total of 312,085 patients from 20 different countries. These papers were reviewed, critically appraised and summarised in table format. Percutaneous cholecystostomy tube drainage is an important treatment modality with an excellent safety profile. It has been used successfully both as a definitive procedure and as a bridge to surgery. There continues to be great variation, however, when it comes to the indications, timing and management of these drains. As far as we are aware, this is the only systematic review to cover the past 10 years. It provides a much-needed update, considering all the technological development and new treatment options in laparoscopic surgery and interventional radiology.
APA, Harvard, Vancouver, ISO, and other styles
41

DÖNMEZ, Mustafa, Zuhal Özgün ERKESKİN, Tezcan AKIN, Erdinç ÇETİNKAYA, Özgür AKGÜL, Ali Emre AKGÜN, Hüseyin BERKEM, Bülent Cavit YÜKSEL, and Sadettin ER. "Acute cholecystitis during the COVID-19 pandemic: is percutaneous cholecystostomy a good alternative for treatment?" Journal of Health Sciences and Medicine 5, no. 6 (October 25, 2022): 1572–75. http://dx.doi.org/10.32322/jhsm.1164599.

Full text
Abstract:
Aim: To evaluate the efficacy, safety, and results of percutaneous cholecystostomy in patients with acute cholecystitis diagnosed with COVID-19. Material and Method: The demographic characteristics, comorbidities, and acute cholecystitis grading of patients according to the Tokyo guideline 2018 (TG18) were evaluated. Mortality, laboratory parameters, radiological findings, physical status scores according to the American Society of Anesthesiologists (ASA) assessment, and the Charlson Comorbidity Index (CCI) were retrospectively evaluated in a total of 38 patients who underwent percutaneous cholecystostomy. Results: The mean age of the 38 patients was 75±9 years, and 21 (55.3%) were female and 17 (44.7%) were male. According to TG18, 33 (86.8%) of the patients had grade II and five (13.2%) had grade III cholecystitis, while there was no grade I case. The mean CCI of the patients was 7.32±2.1. The ASA scores were mostly IIIE, followed by IIE. The COVID-19 test was positive in 33 (86.8%) of the patients. Mortality developed in four (10.5%) patients during hospitalization. Conclusion: Percutaneous cholecystostomy can be considered as a safe, effective, and alternative method in the treatment of patients with acute cholecystitis.
APA, Harvard, Vancouver, ISO, and other styles
42

Kumar H. R. "Current Management of Acute Cholecystitis: A Narrative Review." Asian Journal of Medicine and Health 22, no. 1 (January 29, 2024): 57–63. http://dx.doi.org/10.9734/ajmah/2024/v22i1975.

Full text
Abstract:
Acute calculous cholecystitis is a common condition that results in upper abdominal pain and this condition is diagnosed with leukocytosis and ultrasound of the abdomen. The Tokyo guidelines have categorized them into three groups according to the severity of the disease. Laparoscopic cholecystectomy is the gold standard in the management of acute cholecystitis with early cholecystectomy being preferred to delayed cholecystectomy. The timing of early cholecystectomy is still being debated. Percutaneous cholecystostomy is used as a bridging procedure for high-risk patients. We have conducted this review article to look at the role of antibiotics, the timing of cholecystectomy and indication of percutaneous cholecystostomy in the management of acute calculous cholecystitis.
APA, Harvard, Vancouver, ISO, and other styles
43

Malik, Adnan, and Charalampos Seretis. "Use of percutaneous cholecystostomy for complicated acute lithiasic cholecystitis: solving or deferring the problem?" Polish Journal of Surgery 93, SUPLEMENT (October 20, 2021): 7–12. http://dx.doi.org/10.5604/01.3001.0015.4211.

Full text
Abstract:
<b>Introduction:</b> Percutaneous cholecystostomies are not infrequently used as an adjunct in the treatment of severe lithiasic cholecystitis, particularly in unstable and comorbid patients. However, their out of proportion liberal use tends to substitute the performance of emergency cholecystectomy, which the definitive treatment. </br></br> <b>Aim:</b> Our aim was to assess the short and long-term outcomes of patients who had percutaneous cholecystostomy insertion due to severe lithiasic cholecystitis, aiming to define areas for improvement of our institutional practice. </br></br> <b>Materials and Methods:</b> Retrospective review of our institutional practice including all patients who had a percutaneous cholecystostomy for complex lithiasic cholecystitis, over a 5-year period, allowing for an additional 1-year follow up. </br></br> <b>Results:</b> A total of 34 patients were included in our final analysis. Percutaneous cholecystostomy insertion enabled quick and efficient control of the source of biliary sepsis without major procedural complications in all cases. In 14 (41.2%) patients, cholecystostomy alone served as definitive treatment, while in 20 (58.9%) cases it was used as bridging strategy for delayed elective cholecystectomy. In the delayed cholecystectomy group of patients, we noted a high conversion rate from laparoscopic to open surgery rate of 70%, with an overall subtotal cholecystectomy rate of 60%. </br></br> <b>Conclusion:</b> Percutaneous cholecystostomies should be reserved only for complex lithiasic cholecystitis patients who are unwilling and/or unfit for surgery. We advocate the performance of upfront emergency cholecystectomy in any other case with liberal use of operative bail-out strategies, as a delayed elective operation is anyway likely to be converted to open and/or subtotal cholecystectomy.
APA, Harvard, Vancouver, ISO, and other styles
44

Podoluzhny, V. I., K. A. Krasnov, and N. V. Zarutskaja. "Timing of the termination of mechanical jaundice after antegrade and retrograde decompressive surgeries in mechanical jaundice of various genesis." Herald of Pancreatic Club 45, no. 4 (October 30, 2019): 60–64. http://dx.doi.org/10.33149/vkp.2019.04.08.

Full text
Abstract:
Aim: to determine in a comparative aspect the effectiveness of various minimally invasive decompressive operations in mechanical jaundice of different genesis. Materials and methods. In 135 patients with mechanical jaundice, the rate of bile duct resolution after cholecystostomy and percutaneous cholangiostomy was studied on the background of pancreatic head tumor. In 643 patients with obstructive bile duct disease in cholelithiasis, timing of the termination of jaundice after minimally invasive retrograde (endoscopic papillosphincterotomy (EPT) and EPT with transpapillary drainage) and percutaneous antegrade (cholecystostomy and cholangiostomy) of decompressive operations was studied. Result. Upon cholelithiasis and hyperbilirubinemia less than 100 μmol/l, jaundice is terminated after both variants of retrograde decompression within 3–5 days, antegrade interventions increase these terms by half. Comparison of retrograde and antegrade decompressive surgeries in mechanical jaundice of medium and severe degree on the background of cholelithiasis indicates that the rate of termination of bile stasis is the highest after EPT with transpapillary drainage. Isolated EPT and percutaneous cholangiostoma with medium-grade gallstones increase the duration of jaundice termination by an average of one week. Upon hyperbilirubinemia more than 200 μmol/l, cholangiostomy is not worse than transpapillary drainage. The longest termination period of obstructive jaundice (28–30 days) is observed after superimposition of microcholecystostoma. In patients with jaundice of a mild degree of tumor genesis, no differences in the results were revealed after both variants of percutaneous decompression. Upon hyperbilirubinemia above 100 μmol/l, when cholangio- and cholecystostomy were compared, a higher rate of decrease in serum bilirubin was observed after percutaneous interventions with a cholecystostomy. Conclusion. At all severity levels of mechanical jaundice on the background of cholelithiasis, the best way of decompression is endoscopic papillotomy with transpapillary drainage. In obturation bile stasis upon the pancreatic head tumor, the best decompressive effect is observed after percutaneous cholecystoostomy.
APA, Harvard, Vancouver, ISO, and other styles
45

Cope, C. "Percutaneous subhepatic cholecystostomy with removable anchor." American Journal of Roentgenology 151, no. 6 (December 1988): 1129–32. http://dx.doi.org/10.2214/ajr.151.6.1129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Kang, Sung Gwon, Ho Young Song, Hyun Ki Yoon, Young Suk Lee, Won Woo Kim, and Gyu Bo Sung. "Percutaneous Cholecystostomy : 60 Cases of Experience." Journal of the Korean Radiological Society 34, no. 1 (1996): 89. http://dx.doi.org/10.3348/jkrs.1996.34.1.89.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Marcaire, Fanny, François Malavieille, Virginie Pichot-Delahaye, Bernard Floccard, and Thomas Rimmelé. "Hepatic Compartment Syndrome Following Percutaneous Cholecystostomy." Critical Care Medicine 44, no. 3 (March 2016): e174-e177. http://dx.doi.org/10.1097/ccm.0000000000001403.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Ghahreman, A., J. L. Mccall, and J. A. Windsor. "CHOLECYSTOSTOMY: A REVIEW OF RECENT EXPERIENCE." ANZ Journal of Surgery 69, no. 12 (December 1999): 837–40. http://dx.doi.org/10.1046/j.1440-1622.1999.01712.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Vogelzang, Robert. "Percutaneous Cholecystostomy: Current Concepts and Practice." Seminars in Interventional Radiology 13, no. 03 (September 1996): 215–27. http://dx.doi.org/10.1055/s-2008-1057907.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Friedrich, Ann-Kristin U., Kevin P. Baratta, Joanne Lewis, Adib R. Karam, Margaret Hudlin, Demetrius E. M. Litwin, and Mitchell A. Cahan. "Cholecystostomy Treatment in an ICU Population." Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 26, no. 5 (October 2016): 410–16. http://dx.doi.org/10.1097/sle.0000000000000319.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography